Bridgebio Oncology Therapeutics, Inc. (BBOT)
1.815
-0.04
(-2.42%)
USD |
NASDAQ |
Nov 20, 16:00
1.815
0.00 (0.00%)
After-Hours: 16:15
Bridgebio Oncology Therapeutics Total Liabilities (Quarterly) : 52.84M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 52.84M |
| June 30, 2026 | 53.59M |
| March 31, 2026 | 45.37M |
| December 31, 2025 | 37.98M |
| September 30, 2025 | 38.09M |
| June 30, 2025 | 8.149M |
| March 31, 2025 | 7.391M |
| Date | Value |
|---|---|
| December 31, 2024 | 19.59M |
| September 30, 2024 | 5.647M |
| June 30, 2024 | 5.599M |
| March 31, 2024 | 5.543M |
| December 31, 2023 | 0.3965M |
| December 31, 2022 | 0.1665M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 45.56M |
| IRulya Therapeutics, Inc. | 28.37M |
| PepGen Inc. | 24.71M |
| Q32 Bio, Inc. | 9.531M |
| Oncolytics Biotech, Inc. | 13.34M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 346.22M |
| Shareholders Equity (Quarterly) | 293.39M |
| Debt to Equity Ratio | 0.0081 |
| Current Ratio | 4.083 |
| Net Debt Paydown Yield | -0.14% |